Developer docs
API playgroundTry for free, no card

Search company profiles

SkillCell

Full company profile

uuid000r8x4

Namestring
SkillCell
Legal namestring
SkillCell
Company typeenum
Private
Founded yearint
2017
Descriptiontext

SkillCell is a French biotechnology company founded in 2017 and headquartered in Jarry, Guadeloupe, with research facilities in Grabels/Montpellier and an office in Paris. The firm operates as a subsidiary of ALCEN Group, the mid-sized French industrial conglomerate that co-founded SkillCell alongside CNRS, embedding the company within a public-private partnership that combines ALCEN's industrial scale with CNRS research infrastructure via the Sys2Diag laboratory and a 2,000 square-meter R&I platform.

The company's product platform is "non-living biomachines" — programmable, cell-like devices roughly 30 micrometers in size, composed of a phospholipid bilayer membrane encapsulating a biochemical network of enzymes. Produced with microfluidic technology and designed via a proprietary AI-assisted computational tool, these biomachines detect molecular biomarkers without laboratory equipment and produce colorimetric results in 15-40 minutes. The platform is operationalized in three commercial applications: IDIR® (the first CE-marked urine test for insulin-resistance identification), EasyCOV® (the first CE-marked saliva test for Covid-19, validated at Montpellier University Hospital), and WELLMOTION™ SMILE (saliva-based real-time emotion detection launched in 2025 with fragrance partner MANE). The same architecture is applied to environmental work, notably chlordecone pesticide detection funded by the European Regional Development Fund in the French Caribbean.

SkillCell monetizes through three revenue streams: sale of CE-marked diagnostic products to healthcare professionals and institutions, contract R&D and production services for industrial partners in healthcare, food, agriculture, and environmental sectors, and licensing of its biomachine IP for white-label integration. Distribution relies on direct B2B field sales, technology licensing agreements, and partnerships anchored by named collaborations with CNRS, CEA, Montpellier CHU, MANE, and customers including VOGO, FIRALIS, and Innov Biotech. The company is pursuing ISO 13485 certification and additional CE-marked products, with a "Coming Soon" diagnostic and an miRNA detection program in pipeline.

Short descriptiontext

SkillCell is a French biotechnology subsidiary of ALCEN Group that develops programmable non-living biomachines, commercializing CE-marked diagnostic tests such as the IDIR insulin-resistance urine test, the EasyCOV Covid-19 saliva test, and the WELLMOTION SMILE emotion-detection assay for healthcare, industrial, and consumer-goods partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMontpellier, France
HQ citystring
Montpellier
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
programmable biomachines diagnostics, molecular biomarker detection, point-of-care diagnostics, RT-LAMP salivary testing, non-invasive health tests
Industry3 codes
PRIMARYHLAGADAG
Proteomics & Biomarker Analytical Testing
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Biotechnology / Molecular Diagnostics
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Diagnostic Products Sales
TypeOne Time License
Description

Sale of CE-marked diagnostic test products including IDIR (urine test for insulin resistance) and EasyCOV (Covid-19 salivary test) to healthcare professionals and institutions.

skillcell-alcen.com
2Technology Development Services
TypeProfessional Services
Description

SkillCell offers its patented technology and know-how to industrial partners and third parties, developing products based on customer specifications. Supports customers throughout test design, development, optimization, and industrialization.

skillcell-alcen.com
3Technology Licensing
TypeLicensing Royalties
Description

Licensing of proprietary non-living biomachine technology and related know-how to industrial partners for development of custom diagnostic and detection products.

skillcell-alcen.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1AforHEALTH
Description

Sub-brand associated with SkillCell's health-focused products and applications.

skillcell-alcen.com
Core offering1 text field

SkillCell develops and commercializes programmable non-living biomachine ("lab-in-a-drop") diagnostic technology that detects molecular biomarkers without laboratory equipment. Its commercial product portfolio includes the CE-marked IDIR® urine test for insulin resistance, the CE-marked EasyCOV® Covid-19 saliva test, and the WELLMOTION™ SMILE saliva-based emotion identification system for fragrance research, supported by contract R&D, custom development, and technology licensing services for industrial partners in health, food, agriculture, and environment sectors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • IDIR: Sensitivity 90.6% - Specificity 69.0% (vs HOMA reference standard)
+3 more records
Product overview1 text field

SkillCell offers a portfolio of biology-based diagnostic products centered on its core Non-Living Biomachines technology—a programmable 'lab-in-a-drop' platform that detects molecular biomarkers without equipment. This technology underpins multiple commercial products: IDIR® (the first CE-marked urine test for insulin-resistance, delivering results in 15 minutes), EasyCOV® (the first CE-marked saliva test for Covid-19 with 40-minute results), and WELLMOTION™ SMILE (real-time emotion identification via saliva analysis for fragrance research). The company also provides pesticide detection services for environmental monitoring and offers contract R&D and production services to industrial partners.

Product and service5 records
1IDIR® Urine Test for Insulin-Resistance Identification
CategoryCE-marked diagnostic product (urine test)
Description

The first CE-marked urine test for insulin-resistance identification. A colorimetric test that detects insulin resistance in 15 minutes through urinary branched-chain amino acid (uBCAA) biomarkers, addressing overweight/obesity and metabolic disorders such as Type 2 Diabetes. Sensitivity 90.6%, Specificity 69.0%, intended for clinical use.

2EasyCOV® Covid-19 Salivary Rapid Molecular Test
CategoryCE-marked diagnostic product (saliva molecular test)
Description

The first CE-marked saliva test for Covid-19. A rapid molecular diagnostic test using RT-LAMP technology that provides colorimetric results (yellow for positive, orange for negative) within 40 minutes. Sensitivity 86%, Specificity 99%, CE-marked for Point Of Care use by healthcare professionals only.

3WELLMOTION™ SMILE
CategorySaliva-based biomarker analysis product
Description

Real-time emotion identification through saliva sample analysis. A patented method (WO2025141188) that captures emotional responses induced by fragrances using unique biological markers in a non-invasive saliva-based technology, included in MANE's WELLMOTION™ fragrance emotion program.

4Pesticide Detection Service
CategoryEnvironmental monitoring service
Description

Environmental measurement and data analysis services for chlordecone pesticide detection, providing operational protocols for environmental measurement, sampling campaigns, data consolidation, and reporting for decision-makers in the French Caribbean.

5R&D and Production Services
CategoryContract R&D and manufacturing services
Description

Full-service contract product development from test design through industrialization. Services include test design, development, optimization, and production based on customer specifications, with access to the 2,000 sqm Montpellier Research and Innovation facility (Next-Generation Sequencing, microfluidics, and biocomputing platforms).

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

ALCEN Group is a mid-sized French industrial group developing unique technologies worldwide. Co-founded SkillCell alongside CNRS. ALCEN brings industrial vision and operational capabilities, complementing the scientific research strength of CNRS.

2CNRS (French National Center for Scientific Research)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

CNRS is the largest governmental scientific research institution in France with over 30,000 employees. Co-founded SkillCell alongside ALCEN. Provides fundamental research capabilities and the Sys2Diag laboratory partnership for applied diagnostic development.

skillcell-alcen.com
Strategic tierCoreTypeTechnology or Integration
Description

A private-public research structure created within CNRS to fast-track development of innovative approaches in the diagnosis sector. Combines expertise in medical research, biotechnology design and algorithm development. Provides SkillCell access to cutting-edge 2,000 sqm R&I facilities.

4Montpellier CHU (University Hospital Center)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates with SkillCell on development and clinical validation of the first CE-marked urine test for insulin-resistance identification (IDIR). CHU provides clinical study capabilities and validation at Montpellier public teaching hospital.

skillcell-alcen.com
5MANE
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leader in fragrance creation. MANE collaborates with SkillCell and CNRS on the WELLMOTION program, using the SMILE technology to provide emotional signatures for perfume development. Translates scientific emotional response insights into emotionally resonant scents.

skillcell-alcen.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Diagnostic and molecular diagnostics specialist with significant PCR/molecular-assay footprint (including through Mobidiag acquisition). Comparable to SkillCell in commercializing molecular infectious-disease diagnostics (e.g., Panther system Aptima assays) at global scale.

TypeBroad incumbent
Description

Global sample-prep and molecular-diagnostics company with CE-IVD assays across infectious disease, oncology, and companion diagnostics. Comparable to SkillCell in offering CE-marked molecular diagnostic kits combined with licensing/technology partnerships to industrial clients.

TypeBroad incumbent
Description

French-headquartered global IVD leader with a deep portfolio of CE-marked molecular and immunoassay diagnostics, including point-of-care and clinical lab solutions. Highly comparable to SkillCell as a French diagnostics developer commercializing CE-marked molecular tests (e.g., its BioFire platform) at far greater scale.

TypeBroad incumbent
Description

Develops and markets molecular diagnostic tests (GeneXpert) for infectious disease and other indications. Comparable to SkillCell in building CE/FDA-cleared, cartridge-based molecular diagnostics positioned for point-of-care use.

TypeOthers
Description

Engineered-enzyme and synthetic biology company offering protein-engineering platforms and licensing for life sciences applications. Comparable to SkillCell as a synthetic-biology/IP-licensing-based company commercializing proprietary biomolecular platforms.

TypeEmerging player
Description

U.S. molecular diagnostics company developing CRISPR- and synthetic-biology-driven rapid tests for infectious disease and oncology. Comparable to SkillCell as a smaller-scale, platform-based molecular-diagnostics developer commercializing rapid, equipment-light tests.

TypeEmerging player
Description

Synthetic biology platform company providing DNA synthesis and engineered biological libraries, with expansion into next-generation sequencing and biodiagnostics. Comparable to SkillCell as a synthetic-biology platform company supplying engineered biological building blocks for diagnostic and biotech applications.

TypeEmerging player
Description

U.S. synthetic biology company developing engineered enzymes and biological manufacturing routes for pharmaceuticals and fine chemicals. Comparable to SkillCell in leveraging synthetic biology/enzymatic networks as a programmable platform for new product development.

TypeDirect peer
Description

Originally a Finnish molecular diagnostics developer (now part of Hologic) focused on multiplexed PCR-based infectious disease testing, including sample-to-answer platforms with CE marking. Comparable to SkillCell in clinical molecular IVDs for infectious disease.

10Abbott Diagnostics
TypeBroad incumbent
Description

Global IVD leader spanning immunoassays, clinical chemistry, and point-of-care molecular testing (e.g., Binax, ID NOW). Comparable to SkillCell across broad CE-marked diagnostic menu and large installed testing infrastructure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SkillCell

Biotechnology / Molecular Diagnosticsskillcell-alcen.com

SkillCell is a French biotechnology subsidiary of ALCEN Group that develops programmable non-living biomachines, commercializing CE-marked diagnostic tests such as the IDIR insulin-resistance urine test, the EasyCOV Covid-19 saliva test, and the WELLMOTION SMILE emotion-detection assay for healthcare, industrial, and consumer-goods partners.

What SkillCell does

SkillCell is a French biotechnology company founded in 2017 and headquartered in Jarry, Guadeloupe, with research facilities in Grabels/Montpellier and an office in Paris. The firm operates as a subsidiary of ALCEN Group, the mid-sized French industrial conglomerate that co-founded SkillCell alongside CNRS, embedding the company within a public-private partnership that combines ALCEN's industrial scale with CNRS research infrastructure via the Sys2Diag laboratory and a 2,000 square-meter R&I platform.

The company's product platform is "non-living biomachines" — programmable, cell-like devices roughly 30 micrometers in size, composed of a phospholipid bilayer membrane encapsulating a biochemical network of enzymes. Produced with microfluidic technology and designed via a proprietary AI-assisted computational tool, these biomachines detect molecular biomarkers without laboratory equipment and produce colorimetric results in 15-40 minutes. The platform is operationalized in three commercial applications: IDIR® (the first CE-marked urine test for insulin-resistance identification), EasyCOV® (the first CE-marked saliva test for Covid-19, validated at Montpellier University Hospital), and WELLMOTION™ SMILE (saliva-based real-time emotion detection launched in 2025 with fragrance partner MANE). The same architecture is applied to environmental work, notably chlordecone pesticide detection funded by the European Regional Development Fund in the French Caribbean.

SkillCell monetizes through three revenue streams: sale of CE-marked diagnostic products to healthcare professionals and institutions, contract R&D and production services for industrial partners in healthcare, food, agriculture, and environmental sectors, and licensing of its biomachine IP for white-label integration. Distribution relies on direct B2B field sales, technology licensing agreements, and partnerships anchored by named collaborations with CNRS, CEA, Montpellier CHU, MANE, and customers including VOGO, FIRALIS, and Innov Biotech. The company is pursuing ISO 13485 certification and additional CE-marked products, with a "Coming Soon" diagnostic and an miRNA detection program in pipeline.

SkillCell firmographics

Firmographics
Name
SkillCell
Legal name
SkillCell
Website
https://skillcell-alcen.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
SkillCell is a French biotechnology subsidiary of ALCEN Group that develops programmable non-living biomachines, commercializing CE-marked diagnostic tests such as the IDIR insulin-resistance urine test, the EasyCOV Covid-19 saliva test, and the WELLMOTION SMILE emotion-detection assay for healthcare, industrial, and consumer-goods partners.
Ownership category
akta.pro rank

SkillCell industry classification

Industry
Product category
Biotechnology / Molecular Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGADAG
Proteomics & Biomarker Analytical Testing
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Programmable biomachines diagnostics
  • Molecular biomarker detection
  • Point-of-care diagnostics
  • RT-LAMP salivary testing
  • Non-invasive health tests

Where SkillCell is headquartered

Location

Headquarters

HQ city
Montpellier
HQ country
France
HQ region
Europe

Offices3 records

Markets served

SkillCell business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Diagnostic Products Sales: Sale of CE-marked diagnostic test products including IDIR (urine test for insulin resistance) and EasyCOV (Covid-19 salivary test) to healthcare professionals and institutions.
  2. Technology Development Services: SkillCell offers its patented technology and know-how to industrial partners and third parties, developing products based on customer specifications. Supports customers throughout test design, development, optimization, and industrialization.
  3. Technology Licensing: Licensing of proprietary non-living biomachine technology and related know-how to industrial partners for development of custom diagnostic and detection products.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

SkillCell product offering

Product offering

Core offering

SkillCell develops and commercializes programmable non-living biomachine ("lab-in-a-drop") diagnostic technology that detects molecular biomarkers without laboratory equipment. Its commercial product portfolio includes the CE-marked IDIR® urine test for insulin resistance, the CE-marked EasyCOV® Covid-19 saliva test, and the WELLMOTION™ SMILE saliva-based emotion identification system for fragrance research, supported by contract R&D, custom development, and technology licensing services for industrial partners in health, food, agriculture, and environment sectors.

Product overview

SkillCell offers a portfolio of biology-based diagnostic products centered on its core Non-Living Biomachines technology—a programmable 'lab-in-a-drop' platform that detects molecular biomarkers without equipment. This technology underpins multiple commercial products: IDIR® (the first CE-marked urine test for insulin-resistance, delivering results in 15 minutes), EasyCOV® (the first CE-marked saliva test for Covid-19 with 40-minute results), and WELLMOTION™ SMILE (real-time emotion identification via saliva analysis for fragrance research). The company also provides pesticide detection services for environmental monitoring and offers contract R&D and production services to industrial partners.

Differentiator

Problem solved

Functional benefit

Brands

  • AforHEALTH: Sub-brand associated with SkillCell's health-focused products and applications.

Products and services

  • IDIR® Urine Test for Insulin-Resistance Identification The first CE-marked urine test for insulin-resistance identification. A colorimetric test that detects insulin resistance in 15 minutes through urinary branched-chain amino acid (uBCAA) biomarkers, addressing overweight/obesity and metabolic disorders such as Type 2 Diabetes. Sensitivity 90.6%, Specificity 69.0%, intended for clinical use.
  • EasyCOV® Covid-19 Salivary Rapid Molecular Test The first CE-marked saliva test for Covid-19. A rapid molecular diagnostic test using RT-LAMP technology that provides colorimetric results (yellow for positive, orange for negative) within 40 minutes. Sensitivity 86%, Specificity 99%, CE-marked for Point Of Care use by healthcare professionals only.
  • WELLMOTION™ SMILE Real-time emotion identification through saliva sample analysis. A patented method (WO2025141188) that captures emotional responses induced by fragrances using unique biological markers in a non-invasive saliva-based technology, included in MANE's WELLMOTION™ fragrance emotion program.
  • Pesticide Detection Service Environmental measurement and data analysis services for chlordecone pesticide detection, providing operational protocols for environmental measurement, sampling campaigns, data consolidation, and reporting for decision-makers in the French Caribbean.
  • R&D and Production Services Full-service contract product development from test design through industrialization. Services include test design, development, optimization, and production based on customer specifications, with access to the 2,000 sqm Montpellier Research and Innovation facility (Next-Generation Sequencing, microfluidics, and biocomputing platforms).

Quantifiable outcome

  • IDIR: Sensitivity 90.6% - Specificity 69.0% (vs HOMA reference standard)
  • +3 more outcomes

Companies that use SkillCell

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles4 records

SkillCell technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

SkillCell partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • ALCEN GroupcoreStrategic or Co-development Partner · 1 January 2017ALCEN Group is a mid-sized French industrial group developing unique technologies worldwide. Co-founded SkillCell alongside CNRS. ALCEN brings industrial vision and operational capabilities, complementing the scientific research strength of CNRS.
  • CNRS (French National Center for Scientific Research)coreStrategic or Co-development Partner · 1 January 2017CNRS is the largest governmental scientific research institution in France with over 30,000 employees. Co-founded SkillCell alongside ALCEN. Provides fundamental research capabilities and the Sys2Diag laboratory partnership for applied diagnostic development.
  • Sys2Diag (CNRS Laboratory)coreTechnology or IntegrationA private-public research structure created within CNRS to fast-track development of innovative approaches in the diagnosis sector. Combines expertise in medical research, biotechnology design and algorithm development. Provides SkillCell access to cutting-edge 2,000 sqm R&I facilities.
  • Montpellier CHU (University Hospital Center)coreStrategic or Co-development PartnerCollaborates with SkillCell on development and clinical validation of the first CE-marked urine test for insulin-resistance identification (IDIR). CHU provides clinical study capabilities and validation at Montpellier public teaching hospital.
  • MANEcoreStrategic or Co-development PartnerLeader in fragrance creation. MANE collaborates with SkillCell and CNRS on the WELLMOTION program, using the SMILE technology to provide emotional signatures for perfume development. Translates scientific emotional response insights into emotionally resonant scents.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

SkillCell competitors and assessment

Company assessment

Broad incumbents

  • Hologic: Diagnostic and molecular diagnostics specialist with significant PCR/molecular-assay footprint (including through Mobidiag acquisition). Comparable to SkillCell in commercializing molecular infectious-disease diagnostics (e.g., Panther system Aptima assays) at global scale.
  • QIAGEN: Global sample-prep and molecular-diagnostics company with CE-IVD assays across infectious disease, oncology, and companion diagnostics. Comparable to SkillCell in offering CE-marked molecular diagnostic kits combined with licensing/technology partnerships to industrial clients.
  • bioMérieux: French-headquartered global IVD leader with a deep portfolio of CE-marked molecular and immunoassay diagnostics, including point-of-care and clinical lab solutions. Highly comparable to SkillCell as a French diagnostics developer commercializing CE-marked molecular tests (e.g., its BioFire platform) at far greater scale.
  • Cepheid (a Danaher company): Develops and markets molecular diagnostic tests (GeneXpert) for infectious disease and other indications. Comparable to SkillCell in building CE/FDA-cleared, cartridge-based molecular diagnostics positioned for point-of-care use.
  • Abbott Diagnostics: Global IVD leader spanning immunoassays, clinical chemistry, and point-of-care molecular testing (e.g., Binax, ID NOW). Comparable to SkillCell across broad CE-marked diagnostic menu and large installed testing infrastructure.

Others

  • Codexis: Engineered-enzyme and synthetic biology company offering protein-engineering platforms and licensing for life sciences applications. Comparable to SkillCell as a synthetic-biology/IP-licensing-based company commercializing proprietary biomolecular platforms.

Emerging players

  • Sherlock Biosciences: U.S. molecular diagnostics company developing CRISPR- and synthetic-biology-driven rapid tests for infectious disease and oncology. Comparable to SkillCell as a smaller-scale, platform-based molecular-diagnostics developer commercializing rapid, equipment-light tests.
  • Twist Bioscience: Synthetic biology platform company providing DNA synthesis and engineered biological libraries, with expansion into next-generation sequencing and biodiagnostics. Comparable to SkillCell as a synthetic-biology platform company supplying engineered biological building blocks for diagnostic and biotech applications.
  • Antheia: U.S. synthetic biology company developing engineered enzymes and biological manufacturing routes for pharmaceuticals and fine chemicals. Comparable to SkillCell in leveraging synthetic biology/enzymatic networks as a programmable platform for new product development.

Direct peers

  • Mobidiag (Hologic subsidiary): Originally a Finnish molecular diagnostics developer (now part of Hologic) focused on multiplexed PCR-based infectious disease testing, including sample-to-answer platforms with CE marking. Comparable to SkillCell in clinical molecular IVDs for infectious disease.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

SkillCell social profiles

Digital presence

SkillCell compliance and trust

Trust signal

Compliance5 records

SkillCell financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SkillCell leadership team

Management profile

Number of profiles

Profiles3 records

SkillCell funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SkillCell M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SkillCell

What does SkillCell do?

SkillCell develops and commercializes programmable non-living biomachine ("lab-in-a-drop") diagnostic technology that detects molecular biomarkers without laboratory equipment. Its commercial product portfolio includes the CE-marked IDIR® urine test for insulin resistance, the CE-marked EasyCOV® Covid-19 saliva test, and the WELLMOTION™ SMILE saliva-based emotion identification system for fragrance research, supported by contract R&D, custom development, and technology licensing services for industrial partners in health, food, agriculture, and environment sectors.

Is SkillCell a public or private company?

SkillCell is a private company. It is classified as corporate owned and is currently operating.

When was SkillCell founded?

SkillCell was founded in 2017. It employs 11 to 50 people.

Where is SkillCell based?

SkillCell is headquartered in Montpellier, France, in the Europe region.

How does SkillCell make money?

Three revenue lines are on record. Diagnostic Products Sales are the primary driver. The others are technology Development Services and technology Licensing.

Who are SkillCell's main competitors?

Broad incumbents on record are Hologic, QIAGEN, bioMérieux, Cepheid (a Danaher company) and Abbott Diagnostics. Codexis is listed as an others. Emerging players are Sherlock Biosciences, Twist Bioscience and Antheia. Mobidiag (Hologic subsidiary) is listed as a direct peer.

Does SkillCell have an API?

No public API is recorded for SkillCell.

What industry is SkillCell in?

SkillCell's product category is Biotechnology / Molecular Diagnostics. Its primary akta.pro industry code is HLAGADAG, Proteomics & Biomarker Analytical Testing, with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales